Z-1200-2017Class II
VIDAS 3 software v. 1.1.4
bioMerieux, Inc. / initiated 2017-01-11 / Terminated / root cause: software
BioMerieux SA began a recall of VIDAS 3 software v. 1.1.4 on . FDA classified it as Class II and gives the reason as "During development of the VIDAS 3 software version 1.2, some anomalies have been identified and observed to be already present in the current software version VIDAS 3 version 1.1.4. available in the field". As of , the recall status on record is Terminated, and MDM tags the root cause as software.
Recall record
- Recall number
- Z-1200-2017
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- bioMerieux, Inc.
- Product
- VIDAS 3 software v. 1.1.4
- Product code
- LFZ Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
- Reason for recall
- During development of the VIDAS 3 software version 1.2, some anomalies have been identified and observed to be already present in the current software version VIDAS 3 version 1.1.4. available in the field.
- Root cause tag
- software
- FDA root cause
- Software in the Use Environment
- Action
- Consignees were notified via letter on January 11th, 2017.
- Quantity in commerce
- 1161 units
- Distribution
- U.S.
- Product codes and lots
- REF: #412590, Lot: Software version 1.1.4
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1200-2017 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
